Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05711693
Other study ID # C21-28
Secondary ID 2021-A02896-35
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 1, 2023
Est. completion date July 1, 2024

Study information

Verified date January 2023
Source Institut National de la Santé Et de la Recherche Médicale, France
Contact Pierre Boutouyrie
Phone 0156093991
Email pierre.boutouyrie@aphp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Aortic stiffness is an important imaging biomarker of vascular aging. The ascending aorta is the most elastic segment, and it is excluded by reference non-invasive method carotid to femoral pulse wave velocity (PWV). We propose to use laser-doppler vibrometry (LDV) to record superficial vibrations generated by cardiac activity and arterial pulses for measuring heart carotid PWV, a surrogate for ascending aorta. The trial aims to demonstrate the equivalence between heart-carotid PWV made by laser-doppler vibrometry (LDV) with the reference MRI measurement (4D-FLOW MRI). As secondary objectives, A) we aim to assess the reproducibility of LDV, compared with MRI, B) show that aortic stiffness measured by LDV fulfils international recommendations, C) to study the association between PWV and age or other cardiovascular risk factors, D) assess the acceptability of the measurement. For this, we include 100 consecutive patients, 50 women, 50 men, scheduled for clinically indicated thoracic aorta MRI.


Description:

Cardiovascular (CV) diseases and their risk factors are the leading causes of morbidity and mortality in the world. They are responsible for more than 17.3 million deaths per year worldwide, accounting for 30% of all causes of death. The measurement of arterial stiffness is useful to estimate the global CV risk with more precision than the simple point assessment of the classical cardiovascular risk factors. Carotid-femoral pulse wave velocity (cfPWV) by tonometry is the reference method. However, it excludes by principle the ascending aorta, which is the most distensible and physiologically the most important segment. The InSiDe project aims to measure heart - carotid pulse wave velocity (hcPWV) from the measurement of skin vibrations on the chest and neck by laser doppler vibrometry (LDV), enclosing principally the ascending aorta. This will allow the measurement and validation of a new biomarker that quantifies the stiffness of the ascending aorta. We have demonstrated a very good agreement of the LDV-based cfPWV with the reference technique by tonometry. Our hypothesis, based on physiological reasons, is that heart-carotid PWV will surpass carotid-femoral PWV as a biomarker of large artery stiffness. The trial aims to demonstrate the equivalence between heart-carotid PWV measured by laser-doppler vibrometry (LDV) with the reference MRI measurement (4D-FLOW MRI). MRI, the gold standard comparator is technically demanding and uncomfortable for the patient, much more expensive and not applicable at the general population level. It is therefore likely that measurement by laser-doppler vibrometry, without contact, more comfortable, acceptable and fast, could replace MRI for mass applications. For this, we include 100 consecutive patients, 50 women, 50 men, scheduled for clinically indicated thoracic aorta MRI. ENDPOINTS Primary endpoint: • Heart-carotid PWV measured by LDV. To evaluate the agreement between heart-carotid PWV measured by LDV and the same measurement made by MRI (plus 4D-FLOW MRI) of the thorax. Secondary endpoints: - Reproducibility of the LDV hcPWV - Measurement of LDV cfPWV compared with tonometry - Association between PWV (hc, cf, LDV, MRI), and age, other risk factors - Assessment of patient acceptability of the measurement Statistical analysis The statistical technique used will be the Bland - Altman plot and the corresponding bias assessment (mean Bland-Altman bias and limits of agreement, defined as the mean bias ±1.96 - standard deviation, are provided); the coefficient of variation (CV) will also be used. Description of the device being investigated: The LDV device, developed by the European consortium CARDIS (Medtronic,SIOS, iMEC, Tyndall Institute) uses two arrays with 6 laser beams. It is a non-invasive exploration, by category 1 laser without any risk for the patient and allows to measure the local arterial stiffness (to evaluate the heart-carotid PWV) and segmental without contact with the skin by using the LDV technique. In practice, this device allows the evaluation of the hcPWV from the measurement of skin vibrations on the chest and neck. Description of the device used as a comparator: The reference technique is MRI, used in combination with 4D-FLOW MRI, an innovative technique that allows full 3-dimensional anatomical coverage as well as velocity coding in all 3 directions, opening new and unique possibilities for visualizing and quantifying complex cardiovascular blood flow


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 100
Est. completion date July 1, 2024
Est. primary completion date February 1, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria: - Patients between 18 and 90 years of age in both sexes, who visit the hospital for MRI thoracic MRI as part of routine care. - Enrolled in a social security plan or beneficiary of such a plan. - Free, informed, written consent signed by the participant and the investigator (no later than the day of inclusion and prior to any examination required by the research). and before any examination required by the research and even before the thoracic MRI planned in the care setting). Exclusion Criteria: - Individuals under court protection, guardianship or under curator. - MRI examination done in an emergency context - Patients with skin lesions (severe eczema, wounds, etc.) in the thorax or neck that do not allow the application of not allowing the application of the skin protection film on the area of interest; - Allergies to the adhesive film. - Patients who have a beard, which would make it difficult to apply an adhesive cast. - Subjects who are not affiliated with social security or an equivalent plan. - Refusal or linguistic or psychic incapacity to read the information and not object to the research. - Patients with a serious pathology threatening the vital prognosis in the short and medium term (cancer metastatic cancer, end-stage renal failure, end-stage liver failure, end-stage heart failure) heart failure). - Patients with a history of acute severe (II, IV) heart failure. - Patients with progressive cardiovascular pathologies (unstable coronary artery disease, severe valvular disease,stroke, aortic dissection). - Rhythm disorders: atrial fibrillation, high degree auriculoventricular block. - Pregnant or breastfeeding women - Person subject to an exclusion period for another research

Study Design


Intervention

Device:
Laser doppler vibrometry (LDV), heart(cordium) carotid pulse wave velocity (ccPWV)
Patients scheduled for thoracic aorta MRI will have LDV measurement of ccPWV. Both techniques will be compared
Procedure:
Blood pressure and heart rate measurement
To all patients: - blood pressure and heart rate will be measured
Device:
carotid to femoral PWW measurement
To all patients: - carotid to femoral PWW will be measured by LDV and tonometry for comparison
Procedure:
Questionnaire completion
All patients will complete a questionnaire of acceptability

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Institut National de la Santé Et de la Recherche Médicale, France

Outcome

Type Measure Description Time frame Safety issue
Primary Heart-carotid pulse wave velocity (hcPWV) measured by LDV compared to MRI Values of PWV obtained by LDV and by MRI will be compared. 1 hour
Secondary Reproducibility of LDV heart-carotid pulse wave velocity (hcPWV) Measures will be duplicated and the average calculated, in case of discrepancy > 0.5 m/s, a third measurement is made and the median determined. Two series of measurements will be taken at 5minutes of interval. 1 hour
Secondary Validity of carotid to femoral pulse wave velocity (cfPWV) measured by LDV Values of cfPWV obtained by LDV will be also compared with values obtained by tonometry. 1 hour
Secondary Association of heart-carotid pulse wave velocity (hcPWV) measured by LDV with classical cardiovascular (CV) risk factors and disease The correlation coefficient and linear regression will be calculated. 1 hour
Secondary Acceptability of heart-carotid pulse wave velocity (hcPWV) measured by LDV compared with MRI A questionnaire of acceptability will be completed by the patient after the measurements. 1 hour
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A